Immunotherapy Clinical Trials
At the UPMC Immune Transplant and Therapy Center, our researchers and doctors are bringing cutting-edge clinical trials directly to our patients.
Clinical trials initiated by the UPMC Immune Transplant and Therapy Center explore how we can:
- Harness the immune system to completely reimagine the way we treat transplant patients.
- Find a way to control cancer from within.
- Reduce the effects of chronic diseases as our patients age.
The UPMC Immune Transplant and Therapy Center is also a collaborating and sometimes leading site for industry-sponsored trials researching:
- Tumor infiltrating lymphocytes (TILs) for a range of metastatic and recurrent cancers.
- Chimeric antigen receptor (CAR) T-cell therapies for refractory/relapsed lymphoma and leukemia.
Our researchers are also designing novel applications and enhancements of CAR T cells, with a focus on improving and optimizing their use.
Transplant
